Healthy volunteers to test how two drugs affect each other
NCT ID NCT07619443
First seen Jun 25, 2026 · Last updated Aug 06, 2026 · Updated 7 times
Summary
This early-stage study will give 30 healthy volunteers single doses of two experimental drugs, MK-7262 and enlicitide, to see how they affect each other's levels in the blood. The goal is purely to understand how the drugs interact, not to treat any disease. Results will guide future dosing and safety decisions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- MK-7262 and enlicitide (oral drugs)
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Celerion ( Site 0001)
Lincoln, Nebraska, 68502, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test